Table 2.
Inhibitor | Ki* (nM) |
---|---|
A-14 (9-DA) 2′-OMe | 5.6 ± 0.8 |
A-14 (9-DA) RNA | 3.7 ± 0.7 |
A-14 (9-DA) DNA | 3.1 ± 0.5 |
A-10 (9-DA) 2′-OMe | 4.2 ± 1.3 |
cyclic oxime (9-DA) 2′-OMe | 3.9 ± 0.5 |
cyclic oxime (9-DA) DNA | 2.3 ± 0.1 |
G(9-DA)GA 2′-OMe | 8.7 ± 2.3 |
G(9-DA)Gs3 2′-OMe | 7.5 ± 1.6 |
s3(9-DA)Gs3 2′- OMe | 6.4 ± 1.7 |
s3(9-DA)s3 | 690 ± 100 B |
9-DA | > 0.5 × 106 B |
See Figure 1 for structures of inhibitors.
Values are Ki with no slow onset observed.